Health
Coronavirus vaccine warrior: This man put his life at risk to volunteer for Oxford vaccine development – Times of India
Take a bow! Deepak was made aware of all the risks involved in the process of the clinical trial, including organ failure and mortality, but he still did not have any second thoughts about participating in the same.

As the coronavirus pandemic continues to ravage the world, Deepak Paliwal, a UK citizen of Indian descent, desperately wanted to contribute in any form in this battle against the contagion. Hence, when he heard that Phase 2, clinical trials of the vaccine developed by Oxford University were taking place in five centres in the UK, he knew he had found the way.
Currently, there are more than 150 vaccine candidates in various stages of trials to contain the spread of the novel coronavirus, including AZD1222, formerly known as ChAdOx1 nCoV-1. It is a potential vaccine being developed by the Oxford University. It is made by using a weakened strain of the common cold virus (adenovirus) and combining it with the genetic material of spike protein of the novel coronavirus.

-
Noosa News24 hours ago
Queensland weather forecast sees sunny weather for last week of winter
-
Business22 hours ago
Why the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business23 hours ago
Does Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours ago
Migrants raise concerns over Australia’s English tests for visa applicants